Category: <span>Peritoneal</span>

Study: Early Mesothelioma HIPEC Surgery Extends Survival

Sooner is better when it comes to aggressively treating peritoneal mesothelioma cancer with a combination of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Waiting could cost a patient months of survival. Rejecting surgery could cost them years. The Journal of Gastrointestinal Surgery published a study in November that showed for the first time to what degree […]

The post Study: Early Mesothelioma HIPEC Surgery Extends Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Study Suggests Relationship Between Stromal Tumors and Mesothelioma

Early identification of peritoneal mesothelioma cancer – when it is most effectively treated – may become more common after a recent study revealed a potential link to gastrointestinal stromal tumors. A single-center retrospective review by the division of surgical oncology at University of California San Diego Moores Cancer Center identified a previously underrecognized, synchronous co-occurrence […]

The post Study Suggests Relationship Between Stromal Tumors and Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

MARF to Host International Symposium on Malignant Mesothelioma

Leading medical specialists will gather with mesothelioma patients, families, friends and advocates at the much-anticipated 2022 International Symposium on Malignant Mesothelioma, July 23, in Chicago. This is an event well worth attending. The day-long symposium will be held at Summit Chicago, a welcoming venue where a wide range of mesothelioma experts will be speaking on […]

The post MARF to Host International Symposium on Malignant Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.